Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.
dc.contributor.author | Shah, S S | en_US |
dc.contributor.author | Deshpande, A K | en_US |
dc.contributor.author | Kaundinya, D V | en_US |
dc.date.accessioned | 1995-06-01 | en_US |
dc.date.accessioned | 2009-05-31T01:20:05Z | |
dc.date.available | 1995-06-01 | en_US |
dc.date.available | 2009-05-31T01:20:05Z | |
dc.date.issued | 1995-06-01 | en_US |
dc.description.abstract | Cefoperazone sodium is a broad spectrum third generation Cephalosporin recently introduced in India. This was used as a monotherapy to treat severe infections in hospitalized patients. These infections were due to various gram positive and gram negative organisms. Of the 22 evaluable patients, 21 (95%) were clinically cured and 1 (5%) improved. 18 pathogens were isolated from 17 patients. Microbiologic eradication was 100%. Symptomatic improvement occurred within 48-72 hours of onset of therapy with complete relief by 4-5 days. Dual mode of excretion makes this drug safe in presence of renal insufficiency. Anti-microbial activity against a wide spectrum of organisms and twice daily dosage schedule qualify Cefoperazone as a single antibiotic of choice in severe infections in critically ill patients. | en_US |
dc.description.affiliation | Dept. of Microbiology, Grant Medical College, Bombay. | en_US |
dc.identifier.citation | Shah SS, Deshpande AK, Kaundinya DV. Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience. Journal of the Association of Physicians of India. 1995 Jun; 43(6): 398-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/92084 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 and over | en_US |
dc.subject.mesh | Bacteremia --drug therapy | en_US |
dc.subject.mesh | Cefoperazone --pharmacology | en_US |
dc.subject.mesh | Cephalosporins --pharmacology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gram-Negative Bacterial Infections --drug therapy | en_US |
dc.subject.mesh | Gram-Positive Bacterial Infections --drug therapy | en_US |
dc.subject.mesh | Hospitalization | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Injections, Intravenous | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1